Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tc-99m-labeling of modified RNA.

C S Hilger1, M C Willis, M Wolters

  • 1Schering AG, Research Laboratories, Berlin, FRG.

Nucleosides & Nucleotides
|September 4, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effects of hypothetical behavioral interventions on the 13-year incidence of overweight/obesity in children and adolescents.

The international journal of behavioral nutrition and physical activity·2023
Same author

Dietary calcium intake and adiposity in children and adolescents: Cross-sectional and longitudinal results from IDEFICS/I.Family cohort.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2019
Same author

Potentially modifiable determinants of malnutrition in older adults: A systematic review.

Clinical nutrition (Edinburgh, Scotland)·2019
Same author

Oxidative β-C-H sulfonylation of cyclic amines.

Chemical science·2018
Same author

Blood fatty acid composition in relation to allergy in children aged 2-9 years: results from the European IDEFICS study.

European journal of clinical nutrition·2016
Same author

[Partial Nephrectomy in cT1 Renal Tumours: Conventional Laparoscopic Partial Nephrectomy Compared with LESS Partial Nephrectomy in SITUS Technique].

Aktuelle Urologie·2015
Same journal

PURINE FUNCTIONALIZED CONGENERS AS MOLECULAR PROBES FOR ADENOSINE RECEPTORS.

Nucleosides & nucleotides·2025
Same journal

Mutation induced by deoxyxanthosine in codon 12 of a synthetic c-Ha-ras gene.

Nucleosides & nucleotides·2018
Same journal

A SURVEY OF NONXANTHINE DERIVATIVES AS ADENOSINE RECEPTOR LIGANDS.

Nucleosides & nucleotides·2016
Same journal

SYNTHESIS AND BIOLOGICAL ACTIVITY OF NOVEL 2-THIO DERIVATIVES OF ATP.

Nucleosides & nucleotides·2014
Same journal

Nuclear targeting of antisense oligonucleotides: modification of PRE-mRNA splicing or inhibition of polyadenylation?

Nucleosides & nucleotides·2003
Same journal

Stereoselective synthesis of beta-L-2',3'-dideoxy- and L-2',3'-didehydro-2',3'-dideoxy purine nucleosides.

Nucleosides & nucleotides·2000
See all related articles

Researchers synthesized technetium-99m (Tc-99m)-labeled modified RNA, creating novel radiopharmaceuticals. These Tc-99m-N3S-aptamers show promise as targeted imaging agents for specific biological targets.

Area of Science:

  • Radiochemistry
  • Molecular Imaging
  • Nucleic Acid Chemistry

Background:

  • Development of novel radiopharmaceuticals is crucial for advancing molecular imaging.
  • RNA-based molecules offer unique properties for targeted drug delivery and diagnostics.

Purpose of the Study:

  • To report the synthesis of Tc-99m-labeled modified RNA.
  • To explore the potential of this new class of radiopharmaceuticals as target-specific imaging agents.

Main Methods:

  • Preparation of N3S-RNA by coupling protected MAG2-units to amino-modified oligonucleotides (ONs).
  • Tc-99m labeling of N3S-RNA using established radiolabeling techniques.
  • Characterization of radiochemical yield and specific activity.

Main Results:

Related Experiment Videos

  • Successful synthesis of N3S-RNA achieved.
  • Tc-99m labeling resulted in high radiochemical yields (90-95%).
  • Achieved specific activities of 37 MBq/nmol, forming 1:1 Tc-99m-N3S-aptamers.

Conclusions:

  • A novel method for Tc-99m labeling of modified RNA (N3S-RNA) has been established.
  • The resulting Tc-99m-N3S-aptamers are potential candidates for targeted molecular imaging.
  • This work opens avenues for developing RNA-based radiopharmaceuticals.